Dolutegravir (CAS 1051375-16-6) Antiretroviral Pharmaceutical API

Dolutegravir (CAS 1051375-16-6) is a potent second-generation integrase strand transfer inhibitor (INSTI) and antiretroviral API, acclaimed for its high efficacy against HIV-1 infection. Its optimized molecular structure binds tightly to the HIV integrase active site, blocking viral DNA integration into host cell genomes and suppressing viral replication effectively. This high-purity pharmaceutical raw material meets strict global pharmacopoeial standards, ensuring consistent potency and stability for clinical formulation.

Widely used in antiretroviral therapy (ART) development, it serves as a core ingredient for fixed-dose combination drugs, suitable for both treatment-naive and treatment-experienced HIV patients. Valued for its high genetic barrier to resistance, minimal drug-drug interactions, and once-daily dosing convenience, it addresses the critical need for safe, long-term HIV management solutions. Choose this trusted antiretroviral API to develop high-quality formulations that improve treatment adherence and patient outcomes.